ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A single arm phase Ib study of RAD001 and sunitinib in patients with advanced renal cell carcinoma (RCC).
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.e15034
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. e15034-e15034
Author(s):
J. D. Turnbull
◽
A. J. Armstrong
◽
K. Morris
◽
S. E. Yenser Wood
◽
S. Voyles
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Phase Ib
Download Full-text
Related Documents
Cited By
References
Abstract 2419: A phase Ib-IIa study evaluating the nanopharmaceutical CRLX101 in combination with bevacizumab in the treatment of patients (pts.) with advanced renal cell carcinoma.
10.1158/1538-7445.am2013-2419
◽
2013
◽
Author(s):
Stephen M. Keefe
◽
Roger B. Cohen
◽
Scott Eliasof
◽
Edward G. Garmey
◽
Meliessa Hennessy
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Phase Ib
Download Full-text
Phase Ib trial of a targeted TLR9 CpG immunomodulator (CPG 7909) in advanced renal cell carcinoma (RCC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.4644
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 4644-4644
◽
Cited By ~ 1
Author(s):
J. A. Thompson
◽
T. Kuzel
◽
R. Bukowski
◽
F. Masciari
◽
T. Schmalbach
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Phase Ib
Download Full-text
Phase Ib trial of a targeted TLR9 CpG immunomodulator (CPG 7909) in advanced renal cell carcinoma (RCC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.4644
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 4644-4644
◽
Cited By ~ 9
Author(s):
J. A. Thompson
◽
T. Kuzel
◽
R. Bukowski
◽
F. Masciari
◽
T. Schmalbach
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Phase Ib
Download Full-text
A Phase Ib Study of Combined VEGFR and mTOR Inhibition With Vatalanib and Everolimus in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
◽
10.1016/j.clgc.2013.11.020
◽
2014
◽
Vol 12
(4)
◽
pp. 241-250
◽
Cited By ~ 17
Author(s):
Rhonda L. Bitting
◽
Patrick Healy
◽
Patricia A. Creel
◽
James Turnbull
◽
Karla Morris
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Mtor Inhibition
◽
Phase Ib
Download Full-text
719P Correlative serum biomarker analyses: Lenvatinib (LEN) plus pembrolizumab (PEMBRO) in a phase Ib/II trial in advanced renal cell carcinoma (RCC)
Annals of Oncology
◽
10.1016/j.annonc.2020.08.791
◽
2020
◽
Vol 31
◽
pp. S564-S565
Author(s):
C-H. Lee
◽
Y. Adachi
◽
H. Ikezawa
◽
S.D. Li
◽
Y. Funahashi
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Serum Biomarker
◽
Advanced Renal Cell Carcinoma
◽
Phase Ib
Download Full-text
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3‐Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
The Oncologist
◽
10.1634/theoncologist.2016-0145
◽
2016
◽
Vol 21
(7)
◽
pp. 787
◽
Cited By ~ 45
Author(s):
Maria I. Carlo
◽
Ana M. Molina
◽
Yulia Lakhman
◽
Sujata Patil
◽
Kaitlin Woo
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Mammalian Target Of Rapamycin
◽
Target Of Rapamycin
◽
Advanced Renal Cell Carcinoma
◽
Phosphatidylinositol 3 Kinase
◽
Dual Inhibitor
◽
Phase Ib
◽
Phosphatidylinositol 3
Download Full-text
Phase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC)
Annals of Oncology
◽
10.1093/annonc/mdy283.081
◽
2018
◽
Vol 29
◽
pp. viii308
◽
Cited By ~ 4
Author(s):
N. Agarwal
◽
U. Vaishampayan
◽
M. Green
◽
F. di Nucci
◽
P.-Y. Chang
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Dose Escalation
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Phase Ib
◽
Treatment Naïve
Download Full-text
Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma
Journal for ImmunoTherapy of Cancer
◽
10.1186/2051-1426-3-s2-p353
◽
2015
◽
Vol 3
(S2)
◽
Cited By ~ 16
Author(s):
Michael B Atkins
◽
Shilpa Gupta
◽
Toni K Choueiri
◽
David F McDermott
◽
Igor Puzanov
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Dose Finding
◽
Advanced Renal Cell Carcinoma
◽
Phase Ib
◽
Finding Study
◽
Treatment Naïve
◽
Dose Finding Study
Download Full-text
Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial
European Journal of Cancer
◽
10.1016/j.ejca.2020.12.009
◽
2021
◽
Vol 145
◽
pp. 1-10
Author(s):
Michael B. Atkins
◽
Elizabeth R. Plimack
◽
Igor Puzanov
◽
Mayer N. Fishman
◽
David F. McDermott
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Efficacy And Safety
◽
Phase Ib
◽
Term Efficacy
Download Full-text
First-line (1L) or second-line (2L) avelumab monotherapy in patients (pts) with advanced renal cell carcinoma (aRCC) enrolled in the phase Ib JAVELIN solid tumor trial
Annals of Oncology
◽
10.1093/annonc/mdy283.086
◽
2018
◽
Vol 29
◽
pp. viii310-viii311
◽
Cited By ~ 1
Author(s):
U.N. Vaishampayan
◽
P. Schöffski
◽
A. Ravaud
◽
C. Borel
◽
T. Song
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Solid Tumor
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Second Line
◽
First Line
◽
Phase Ib
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close